Claims for Patent: 5,380,649

Summary for Patent: 5,380,649

Title:	Enzymatic determination of analyte ions in fluids by optimizing measurement levels
Abstract:	A process and a reagent for the determination of ions in fluids, wherein the influence of these ions on the activity of an enzyme is measured. The ions for example are sodium, potassium, calcium, magnesium, manganese, lithium, lead, zinc, copper, iron or other heavy metals or non-metallic ions comprising chloride, bicarbonate, protons, ammonium and substances that give rise to ammonium. The enzymes which are used may be a transferase, a hydrolase, an oxidoreductase or a lyase. An essential feature is a method to exclude interferences by ions by masking the interfering ions with a binding agent.
Inventor(s):	Berry; Michael N. (Eden Hills, AU), Town; Michael-Harold (Oberhausen, DE), Kresse; Georg-Burkhard (Penzberg, DE), Herrmann; Uwe (Bernried, DE)
Assignee:	Boehringer Mannheim GmbH (Mannheim, DE) The Flinders University of South Australia (South Australia, AU)
Application Number:	07/907,731
Patent Claims:	1. Process for the determination of the concentration of an analyte ion in a fluid sample, comprising measuring the activity of an enzyme whose activity is stimulated by the analyte ion and is selected from the group consisting of a transference, a hydrolase, an oxidoreductase or a lyase in the presence of a selective binding agent which binds to the analyte ion in the fluid sample and is present in a quantity sufficient to increase the ratio of the activity of the enzyme to the concentration of free analyte ions in the fluid sample to within an optimal range for measurement of the concentration of analyte ions in the fluid sample wherein the activity of the enzyme is proportional to the concentration of analyte ions in the fluid sample. 2. Process according to claim 1, wherein the fluid sample is a body fluid. 3. Process according to claim 2, wherein the analyte ion is selected from the group consisting of potassium, sodium, calcium, magnesium, manganese, lithium, lead, zinc, copper, iron, chloride, ammonium or substances that give rise to the formation of ammonium. 4. Process according to claim 2, wherein the selective binding agent is selected from the group consisting of a cryptand, coronand, podand, crown ether, spherand, hemispherand, calixaren, a natural occurring ionophore, a cyclic peptide, a complexone or a chelating agent, an alkali metal or alkaline earth metal. 5. Process according to claim 2, wherein the selective binding agent is selected from the group consisting of a cryptand or a chelating agent. 6. Process according to claim 2, wherein said body fluid is selected from the group consisting of blood, serum, plasma, urine, sweat, exudates or transudates. 7. Process according to claim 1, wherein said fluid sample is water. 8. Process according to claim 1, wherein the enzyme is a transferase transferring phosphorus-containing groups. 9. Process according to claim 8, wherein the transferase is selected from the group consisting of pyruvate kinase, hexokinase, adenylate kinase, pyridoxal kinase or acetate kinase. 10. Process according to claim 1, wherein the enzyme is selected from the group consisting of a hydrolase, glycosidase or protease. 11. Process according to claim 10, wherein the hydrolase is selected from the group consisting of .alpha.- or .beta.-D-galactosidase, carboxypeptidase A, collagenase, amylase, Calpain I, Calpain II, dipeptidyl aminopeptidase I (Cathepsin C) or phosphoglycolate phosphatase. 12. Process according to claim 11, wherein the hydrolase is .alpha.- or .beta.-D-galactosidase or carboxypeptidase A. 13. Process according to claim 1, wherein the enzyme is an oxidoreductase which acts on the CH--OH group of donor molecules or on the aldehyde or oxo group of donors. 14. Process according to claim 13, wherein the oxoreductase is selected from the group consisting of glycerol dehydrogenase, acetaldehyde dehydrogenase, or tyrosinase (catechol oxidase). 15. Process according to claim 1, wherein the enzyme is a lyase. 16. Process according to claim 15, wherein the lyase is a carbon-carbon lyase or a carbon-oxygen lyase. 17. Process according to claim 15, wherein the lyase is aldolase or carbonic anhydrase. 18. A composition for the determination of the concentration of an analyte ion in a fluid sample, comprising an enzyme whose activity is stimulated by the analyte ion and is selected from the group consisting of a transferase, a hydrolase, an oxidoreductase or a lyase and a selective binding agent that binds to said analyte ion and is present in a quantity sufficient to increase the ratio of the activity of the enzyme to the concentration of free analyte ions in the fluid sample to within an optimal range for measurement of the concentration of analyte ions in the fluid sample.

Details for Patent 5,380,649

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Smith & Nephew, Inc.	SANTYL	collagenase	Ointment	101995	06/04/1965		2012-01-10